GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. โ GLP-1 News | CED Clinic NewsObservationalMetabolic SyndromeSweetenerEndocrinologyAdults with Metabolic DiseaseInsulin ResistanceLipid MetabolismArtificial SweetenerFat AccumulationCardiometabolic RiskNon-Nutritive Sweetener Why...
GLP-1 Clinical Evidence: Adolescent Metabolic Health
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. โ GLP-1 News | CED Clinic Consensus StatementObservationalAdolescent Metabolic HealthType 2 Diabetes PreventionObesity PreventionPediatric PatientsInsulin ResistanceIncretin EffectEndocrinologyPediatric ObesityMetabolic...
Cannabidiol as a Modulator of the Gut-Liver Axis: Clinical and Pharmacological Insights into Hepatic and Metabolic Disorder Therapies.
A non-intoxicating substance produced from Cannabis sativa, cannabidiol (CBD) has shown promise as a treatment for metabolic and hepatic diseases, primarily …
Scientists Discover How Cannabis Compounds May Fight Fatty Liver Disease – NDTV
โฆ New CED Clinical Relevance#72Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. ResearchCBDHemp Why This MattersClinicians managing patients with nonalcoholic fatty liver disease now have preliminary evidence that CBD and...
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – CBS19
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCHemp Why This Matters This finding is clinically relevant because non-alcoholic fatty liver disease affects...